Akanda Corp (AKAN) Peer Comparison
$4.23
$-0.01
(-0.24%)
As on 27-Aug-2026 16:21EDT
Market cap
$2 Mln
Revenue (TTM)
$4 Mln
P/E Ratio
--
P/B Ratio
2.2
Div. Yield
0 %
Edit
| Akanda Corp (AKAN) | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Arbutus Biopharma Corp (ABUS) | Sundial Growers - ADR | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
2 | 2,409 | 1,219 | 1,031 | 341 |
Revenue ($ Mln) |
0 | 10,853 | 243 | 182 | 928 |
Net Profit ($ Mln) |
-45.65 | -1,098.00 | 69.79 | 153.05 | -21.69 |
Net Margin (%) |
-631.92 | -10.12 | 28.74 | 84.23 | -2.34 |
RoE (%) |
1,402.89 | -- | 5.60 | 91.29 | -2.00 |
Price to Earnings |
-- | -- | 17.42 | 6.06 | -- |
Price-To-Book |
2.21 | 18.78 | 1.14 | 3.64 | 0.44 |
Cashflow ($ Mln)
| Akanda Corp (AKAN) | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Arbutus Biopharma Corp (ABUS) | Sundial Growers - ADR | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-6.73 | 1,400.00 | 26.32 | -39.64 | 70.92 |
|
Cash Flow from Investing Activities
|
-7.45 | -595.00 | -77.90 | 15.58 | 17.45 |
|
Cash from Financing Activities
|
11.68 | -742.00 | -20.25 | 5.72 | -54.49 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Akanda Corp (AKAN) | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Arbutus Biopharma Corp (ABUS) | Sundial Growers - ADR | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-1,129.95 | 0.76 | -0.89 | -36.37 | -1.23 |
|
ROE (%)
|
1,402.89 | -17.14 | -0.89 | -38.52 | -1.41 |
|
ROA (%)
|
-647.13 | 0.59 | -0.81 | -29.60 | -1.17 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
-17,690.19 | 1.53 | -6.44 | -237.88 | -1.67 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Akanda Corp (AKAN) | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Arbutus Biopharma Corp (ABUS) | Sundial Growers - ADR | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-0.69 | 0.07 | 0.27 | 1.28 | 0.03 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
-1,014.59 | 441.30 | -123.40 | 52.09 | 83.36 |
|
EPS Growth (%)
|
-1.44 | 4.43 | -1.23 | 0.52 | 0.83 |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Akanda Corp (AKAN) | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Arbutus Biopharma Corp (ABUS) | Sundial Growers - ADR | |
|---|---|---|---|---|---|
|
Price / Earnings
|
0.00 | 16.40 | -105.42 | -27.51 | -27.71 |
|
Price / Book Value
|
0.00 | -4.66 | 0.93 | 12.04 | 0.40 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-0.30 | 7.07 | -54.50 | -25.25 | 6.96 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Akanda Corp (AKAN) | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Arbutus Biopharma Corp (ABUS) | Sundial Growers - ADR | |
|---|---|---|---|---|---|
|
Debt to Equity
|
-1.32 | -38.35 | 0.00 | 0.05 | 0.15 |
|
Short term debt to equity ratio
|
-0.21 | -0.54 | 0.00 | 0.01 | 0.03 |
|
Current Ratio
|
0.58 | 1.47 | 19.59 | 15.73 | 4.88 |
|
Quick Ratio
|
-- | 1.08 | 18.62 | -- | 3.47 |
|
Interest Coverage
|
-50.20 | 1.23 | -- | -344.37 | -1.10 |
Operating Efficiency Ratios
| Akanda Corp (AKAN) | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Arbutus Biopharma Corp (ABUS) | Sundial Growers - ADR | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
542.47 | 22.86 | 38.35 | 12.41 | 3.22 |
|
Asset Turnover
|
0.04 | 0.39 | 0.13 | 0.12 | 0.70 |
|
Receivable days
|
1,572.41 | 79.82 | 106.48 | 53.89 | 11.30 |
|
Inventory Days
|
0.00 | 195.23 | 166.85 | -- | 68.84 |
|
Payable days
|
2,666.67 | 76.06 | 59.75 | 1,755.31 | 14.63 |
|
Cash Conversion Cycle
|
-1,094.25 | 198.99 | 213.59 | -- | 65.51 |
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
